Details

Autor(en) / Beteiligte

• Ragagnin, Audrey M G
• Sundaramoorthy, Vinod
• Farzana, Fabiha
• Gautam, Shashi
• Saravanabavan, Sayanthooran
• Takalloo, Zeinab
• Mehta, Prachi
• Do-Ha, Dzung
• Parakh, Sonam
• Shadfar, Sina
• Hunter, Julie
• Vidal, Marta
• Jagaraj, Cyril J
• Brocardo, Mariana
• Konopka, Anna
• Yang, Shu
• Rayner, Stephanie L
• Williams, Kelly L
• Blair, Ian P
• Chung, Roger S
• Lee, Albert
• Ooi, Lezanne
• Atkin, Julie D

Titel

ALS/FTD-associated mutation in cyclin F inhibits ER-Golgi trafficking, inducing ER stress, ERAD and Golgi fragmentation

Ist Teil von

• Scientific reports, 2023-11, Vol.13 (1), p.20467-20467, Article 20467

Ort / Verlag

England: Nature Publishing Group

Erscheinungsjahr

2023

Link zum Volltext

Quelle

Electronic Journals Library

Beschreibungen/Notizen

• Amyotrophic lateral sclerosis (ALS) is a severely debilitating neurodegenerative condition that is part of the same disease spectrum as frontotemporal dementia (FTD). Mutations in the CCNF gene, encoding cyclin F, are present in both sporadic and familial ALS and FTD. However, the pathophysiological mechanisms underlying neurodegeneration remain unclear. Proper functioning of the endoplasmic reticulum (ER) and Golgi apparatus compartments is essential for normal physiological activities and to maintain cellular viability. Here, we demonstrate that ALS/FTD-associated variant cyclin F inhibits secretory protein transport from the ER to Golgi apparatus, by a mechanism involving dysregulation of COPII vesicles at ER exit sites. Consistent with this finding, cyclin F also induces fragmentation of the Golgi apparatus and activates ER stress, ER-associated degradation, and apoptosis. Induction of Golgi fragmentation and ER stress were confirmed with a second ALS/FTD variant cyclin F , and in cortical primary neurons. Hence, this study provides novel insights into pathogenic mechanisms associated with ALS/FTD-variant cyclin F, involving perturbations to both secretory protein trafficking and ER-Golgi homeostasis.